Logo for PolyPid Ltd

PolyPid Investor Relations Material

Latest events

Logo for PolyPid Ltd

Status Update

PolyPid
Logo for PolyPid

Status Update

9 Jun, 2025
Logo for PolyPid

Q1 2025

14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from PolyPid Ltd

Access all reports
PolyPid Ltd. is a late-stage biopharmaceutical company focused on enhancing surgical outcomes through innovative drug delivery systems. The company's proprietary PLEX (Polymer-Lipid Encapsulation Matrix) technology is designed to enable localized, prolonged, and controlled release of active pharmaceutical ingredients at the surgical site. This technology aims to optimize therapeutic efficacy and minimize side effects by maintaining a consistent drug presence over an extended period. The company is headquartered in Petach Tikva, Israel, and its shares are listed on the NASDAQ.